Fiduciary duty in health plan administration.
SB 3 establishes that third-party administrators and pharmacy benefit managers, when acting on behalf of a health plan sponsor, owe a fiduciary duty to that sponsor. This means these companies must prioritize the best interests of the plan sponsor in their administration of health plans and management of prescription benefits. The bill directly affects businesses that administer health plans and manage pharmacy benefits, as well as the organizations that sponsor those plans.
Bill status
signed
all 5 stages cleared
Introduction
Jan 2025
Committee Review
Mar 2025
Senate Passage
Apr 2025
House Passage
Apr 2025
Signed into Law
Apr 2025
Introduced Jan 14, 2025
Signed Apr 16, 2025
Maddy AI version diff · 3 comparisons
What changed between versions
Senate Bill (H)
→
Senate Bill (S)
·
4 edits
MODERATE
This bill was amended to narrow its scope by removing 'employee benefit consultant' and 'insurance producer' from the list of parties who owe a fiduciary duty to plan sponsors. The definition of fiduciary duty was also rewritten to be more specific about loyalty, care, fee disclosure, and conflict avoidance. These changes reduce the number of regulated parties and clarify the obligations of those who remain covered.
Scope change
The bill now applies only to third party administrators and pharmacy benefit managers, removing employee benefit consultants and insurance producers from the fiduciary duty requirement.
SCOPE
Removed 'employee benefit consultant' and 'insurance producer' from the list of parties who owe a fiduciary duty to plan sponsors.
DEFINITION
Rewrote the definition of 'fiduciary duty' to specify four obligations: acting with loyalty and care, disclosing fees and commissions, avoiding self-dealing, and maintaining financial transparency.
Reorganized the chapter's definitions by removing separate sections for 'employee benefit consultant', 'insurance producer', and 'insurer', and consolidating remaining definitions.
TECHNICAL
Updated bill numbers and dates to reflect Senate action (ES 3, March 25, 2025) and added House sponsor information.
Floor votes · Senate Feb 17, 2025 · House Mar 31, 2025
How they voted
47–0
Passed · 3 other
Total votes 50
Feb 17, 2025
D
Democratic10
90% Yea
R
Republican40
95% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
25
Key actions
9
Committee
2
Amendments
1
Apr 16, 2025
Signed into law
Signed by the Governor
executive
Apr 9, 2025
Upper · Passed
Signed by the President of the Senate
upper
Apr 8, 2025
Upper · Passed
Signed by the President Pro Tempore
upper
Apr 8, 2025
Lower · Passed
Signed by the Speaker
lower
Apr 3, 2025
Upper · Passed
Senate concurred with House amendments; Roll Call 337: yeas 48, nays 0
upper
Mar 31, 2025
Lower · Passed
Third reading: passed; Roll Call 329: yeas 89, nays 0
lower
Mar 27, 2025
Amended
Amendment #1 (Campbell) failed; Roll Call 317: yeas 28, nays 61
lower
Mar 25, 2025
Lower · Passed
Committee report: amend do pass, adopted
lower
Feb 17, 2025
Upper · Passed
Third reading: passed; Roll Call 134: yeas 47, nays 0
upper
Jan 29, 2025
Upper · Passed
Committee report: amend do pass, adopted
upper
4 primary · 3 co-sponsors
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 3
Scope: IN
Hi! I can help you understand SB 3. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline